ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 14.6
De Novo Posttransplant Solid Malignancy, 1992 to 2001
Kidney Recipients

Malignancies by Type Year of Transplant
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Total # of Post-Tx Malignancies 249 291 299 261 248 256 252 173 108 35
Squamous/Basal Cell Carcinoma 157 181 159 142 138 137 134 97 56 18
Melanoma 4 4 12 10 5 8 4 1 4 -
Kaposi Sarcoma 2 2 3 - 2 - 8 3 3 -
Central Nervous System 2 - 5 5 2 2 1 4 - -
Genito-Urinary (1) 19 25 22 22 16 24 21 14 5 3
Gastro-Intestinal (2) 25 28 38 31 27 30 33 14 14 3
Primary Hepatic Tumor 1 1 1 2 3 4 1 1 2 -
Metastatic Hepatic Tumor - 3 1 2 2 4 6 1 - -
Larynx/Bronchi/Lung 9 12 21 15 15 19 20 15 7 4
Breast/Thyroid/Adrenal 12 11 13 11 18 16 10 13 6 4
Leukemia 1 1 1 - 2 1 - - 1 -
Sarcoma (3) - 3 - 2 1 - 1 - - -
Other 17 19 19 13 15 7 12 9 9 2
Unknown - 1 4 6 2 4 1 1 1 1
Squamous/Basal Cell Carcinoma 63.1% 62.2% 53.2% 54.4% 55.6% 53.5% 53.2% 56.1% 51.9% 51.4%
Melanoma 1.6% 1.4% 4.0% 3.8% 2.0% 3.1% 1.6% 0.6% 3.7% -
Kaposi Sarcoma 0.8% 0.7% 1.0% - 0.8% - 3.2% 1.7% 2.8% -
Central Nervous System 0.8% - 1.7% 1.9% 0.8% 0.8% 0.4% 2.3% - -
Genito-Urinary (1) 7.6% 8.6% 7.4% 8.4% 6.5% 9.4% 8.3% 8.1% 4.6% 8.6%
Gastro-Intestinal (2) 10.0% 9.6% 12.7% 11.9% 10.9% 11.7% 13.1% 8.1% 13.0% 8.6%
Primary Hepatic Tumor 0.4% 0.3% 0.3% 0.8% 1.2% 1.6% 0.4% 0.6% 1.9% -
Metastatic Hepatic Tumor - 1.0% 0.3% 0.8% 0.8% 1.6% 2.4% 0.6% - -
Larynx/Bronchi/Lung 3.6% 4.1% 7.0% 5.7% 6.0% 7.4% 7.9% 8.7% 6.5% 11.4%
Breast/Thyroid/Adrenal 4.8% 3.8% 4.3% 4.2% 7.3% 6.3% 4.0% 7.5% 5.6% 11.4%
Leukemia 0.4% 0.3% 0.3% - 0.8% 0.4% - - 0.9% -
Sarcoma (3) - 1.0% - 0.8% 0.4% - 0.4% - - -
Other 6.8% 6.5% 6.4% 5.0% 6.0% 2.7% 4.8% 5.2% 8.3% 5.7%
Unknown - 0.3% 1.3% 2.3% 0.8% 1.6% 0.4% 0.6% 0.9% 2.9%
Total # of Patients 203 214 231 211 208 211 203 151 94 34

Source: OPTN/SRTR Data as of August 1, 2002.
(-) = None in category.
(1) Genito-Urinary: kidney, bladder, uterine cervix, uterine body, ovarian, vulva, testicular, prostate.
(2) Gastro-Intestinal: tongue, throat, esophagus, stomach, small intestine, colo-rectal, liver and biliary
tract, pancreas.
(3) Sarcoma: fibrosarcoma, osteosarcoma, etc.
Patients may have more than one posttransplant malignancy reported due to multiple follow-up forms.
Recipient malignancy statistics are based on voluntary reporting to the OPTN.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.